Logo image of BMR

BEAMR IMAGING LTD (BMR) Stock Fundamental Analysis

NASDAQ:BMR - Nasdaq - IL0011832438 - Common Stock - Currency: USD

2.9  -0.11 (-3.65%)

After market: 2.92 +0.02 (+0.69%)

Fundamental Rating

2

Overall BMR gets a fundamental rating of 2 out of 10. We evaluated BMR against 284 industry peers in the Software industry. While BMR seems to be doing ok healthwise, there are quite some concerns on its profitability. BMR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

BMR had negative earnings in the past year.
BMR had a negative operating cash flow in the past year.
BMR Yearly Net Income VS EBIT VS OCF VS FCFBMR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -1M -2M

1.2 Ratios

BMR has a worse Return On Assets (-11.48%) than 62.32% of its industry peers.
BMR has a Return On Equity of -12.01%. This is comparable to the rest of the industry: BMR outperforms 46.74% of its industry peers.
Industry RankSector Rank
ROA -11.48%
ROE -12.01%
ROIC N/A
ROA(3y)-13.56%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BMR Yearly ROA, ROE, ROICBMR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 100 -100 200 -200

1.3 Margins

Looking at the Gross Margin, with a value of 95.37%, BMR belongs to the top of the industry, outperforming 98.91% of the companies in the same industry.
In the last couple of years the Gross Margin of BMR has remained more or less at the same level.
BMR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 95.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.12%
GM growth 5YN/A
BMR Yearly Profit, Operating, Gross MarginsBMR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 50 -50

More info and screens

6

2. Health

2.1 Basic Checks

BMR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BMR has been increased compared to 1 year ago.
The debt/assets ratio for BMR has been reduced compared to a year ago.
BMR Yearly Shares OutstandingBMR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2M 4M 6M 8M 10M
BMR Yearly Total Debt VS Total AssetsBMR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

BMR has an Altman-Z score of 24.99. This indicates that BMR is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 24.99, BMR belongs to the top of the industry, outperforming 94.93% of the companies in the same industry.
BMR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of BMR (0.00) is better than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 24.99
ROIC/WACCN/A
WACC8.78%
BMR Yearly LT Debt VS Equity VS FCFBMR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 2M 4M 6M 8M 10M

2.3 Liquidity

BMR has a Current Ratio of 19.24. This indicates that BMR is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 19.24, BMR belongs to the best of the industry, outperforming 98.55% of the companies in the same industry.
BMR has a Quick Ratio of 19.24. This indicates that BMR is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of BMR (19.24) is better than 98.55% of its industry peers.
Industry RankSector Rank
Current Ratio 19.24
Quick Ratio 19.24
BMR Yearly Current Assets VS Current LiabilitesBMR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for BMR have decreased by -8.25% in the last year.
Looking at the last year, BMR shows a small growth in Revenue. The Revenue has grown by 2.41% in the last year.
BMR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.88% yearly.
EPS 1Y (TTM)-8.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-59.62%
Revenue 1Y (TTM)2.41%
Revenue growth 3Y-2.88%
Revenue growth 5YN/A
Sales Q2Q%4.82%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y0%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year20.69%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BMR Yearly Revenue VS EstimatesBMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 1M 2M 3M
BMR Yearly EPS VS EstimatesBMR Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 -0.02 -0.04 -0.06

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BMR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BMR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BMR Price Earnings VS Forward Price EarningsBMR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BMR Per share dataBMR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BMR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BEAMR IMAGING LTD

NASDAQ:BMR (2/21/2025, 8:03:53 PM)

After market: 2.92 +0.02 (+0.69%)

2.9

-0.11 (-3.65%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.14%
Inst Owner ChangeN/A
Ins Owners24.29%
Ins Owner Change0%
Market Cap44.98M
Analysts80
Price Target8.16 (181.38%)
Short Float %4.02%
Short Ratio0.91
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.5
P/FCF N/A
P/OCF N/A
P/B 2.03
P/tB 2.62
EV/EBITDA N/A
EPS(TTM)-0.19
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.25
BVpS1.43
TBVpS1.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.48%
ROE -12.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 95.37%
FCFM N/A
ROA(3y)-13.56%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.12%
GM growth 5YN/A
F-Score4
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 760.61%
Cap/Sales 12.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 19.24
Quick Ratio 19.24
Altman-Z 24.99
F-Score4
WACC8.78%
ROIC/WACCN/A
Cap/Depr(3y)250.51%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.28%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-59.62%
EPS Next Y0%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.41%
Revenue growth 3Y-2.88%
Revenue growth 5YN/A
Sales Q2Q%4.82%
Revenue Next Year20.69%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-19.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-31.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2.17%
OCF growth 3YN/A
OCF growth 5YN/A